NASDAQ:INGN

Inogen - INGN Stock Forecast, Price & News

$24.28

+0.20 (+0.83%)

(As of 09/30/2022 12:00 AM ET)

Add

Compare

Today's Range: $24.16
▼
$24.79
50-Day Range: $22.74
▼
$31.80
52-Week Range: $22.28
▼
$44.30

Volume: 197,402 shs
Average Volume: 162,264 shs
Market Capitalization: $555.28 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $41.00

Inogen MarketRank™ Forecast

Analyst Rating: Hold
2.25 Rating Score
Upside/Downside: 68.9% Upside
$41.00 Price Target
Short Interest: Healthy
3.30% of Float Sold Short
Dividend Strength: N/A
Sustainability: -1.00
Upright™ Environmental Score
News Sentiment: 0.58
Based on 8 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($1.77) to ($1.13) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.26 out of 5 stars

Medical Sector

426th out of 1,093 stocks

Surgical Appliances & Supplies Industry

10th out of 24 stocks

3.1

Analyst's Opinion

Consensus Rating
Inogen has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on 1 buy rating, 3 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $41.00, Inogen has a forecasted upside of 68.9% from its current price of $24.28.
Amount of Analyst Coverage
Inogen has received no research coverage in the past 90 days.

4.0

Short Interest

Percentage of Shares Shorted
3.30% of the float of Inogen has been sold short.
Short Interest Ratio / Days to Cover
Inogen has a short interest ratio ("days to cover") of 4.1.
Change versus previous month
Short interest in Inogen has recently decreased by 21.54%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Inogen does not currently pay a dividend.
Dividend Growth
Inogen does not have a long track record of dividend growth.

3.8

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Inogen has received a 49.08% net impact score from Upright. Inogen seems to create the most significant positive value in categories "Taxes", "Physical diseases", and "Jobs". The positive contribution in the "Physical diseases" impact category is driven by its "Medical ventilators" product. See details.
Environmental Sustainability
The Environmental Impact score for Inogen is -1.00.

2.5

News and Social Media Coverage

News Sentiment
Inogen has a news sentiment score of 0.58. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.82 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 8 news articles for Inogen this week, compared to 3 articles on an average week.
MarketBeat Follows
2 people have added Inogen to their MarketBeat watchlist in the last 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Inogen insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 1.19% of the stock of Inogen is held by insiders.
Percentage Held by Institutions
97.65% of the stock of Inogen is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Inogen are expected to grow in the coming year, from ($1.77) to ($1.13) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Inogen is -19.42, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Inogen is -19.42, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Inogen has a P/B Ratio of 1.49. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Inogen (NASDAQ:INGN) Stock

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

Receive INGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inogen and its competitors with MarketBeat's FREE daily newsletter.

INGN Stock News Headlines

September 29, 2022 | finance.yahoo.com

Europe Energy Crisis Varied Impacts Across Countries - Yahoo Finance

September 25, 2022 | americanbankingnews.com

Inogen (NASDAQ:INGN) Reaches New 1-Year Low at $22.39

September 19, 2022 | finance.yahoo.com

Inogen Alliance Ranks in Environment Analyst's Top 100 Environmental & Sustainability Consultancy Firms 2022 Report - Yahoo Finance

September 19, 2022 | globenewswire.com

Portable Oxygen Kit Market Is Predicted to Reach USD 35.8 Billion by 2031, Says Allied Market Research - GlobeNewswire

September 17, 2022 | nasdaq.com

3 Reasons to Hold Insulet (PODD) Stock in Your Portfolio - Nasdaq

September 16, 2022 | finance.yahoo.com

Inogen (NASDAQ:INGN) Is In A Strong Position To Grow Its Business

September 14, 2022 | finance.yahoo.com

Antea Group Ranked 14th in Environment Analyst's Top 100 Environmental & Sustainability Consultancy Firms 2022 Report - Yahoo Finance

September 14, 2022 | finance.yahoo.com

Ekinops' SixSq and Kadiska deliver network performance monitoring from enterprise edge to cloud, web and SaaS applications - Yahoo Finance

September 13, 2022 | nasdaq.com

3 Reasons to Hold Inogen (INGN) Stock in Your Portfolio - Nasdaq

September 13, 2022 | finance.yahoo.com

3 Reasons to Hold Inogen (INGN) Stock in Your Portfolio

September 13, 2022 | seekingalpha.com

Inogen Stock: Structural, Supply Chain Headwinds Remain (NASDAQ:INGN) - Seeking Alpha

September 12, 2022 | finance.yahoo.com

Inogen, Inc. (INGN)

September 8, 2022 | nasdaq.com

Avanos Medical (AVNS) Down 14% Since Last Earnings Report: Can It Rebound? - Nasdaq

September 8, 2022 | finance.yahoo.com

Heart Pump Device Market Size and Upcoming Technological Innovations Will Boom in 2022-2028 | Analyzed by Size Share, Trends, Key Players & Future Growth Outlook - Yahoo Finance

September 8, 2022 | globenewswire.com

Heart Pump Device Market Size and Upcoming Technological Innovations Will Boom in 2022-2028 | Analyzed by Size Share, Trends, Key Players & Future Growth Outlook - GlobeNewswire

September 8, 2022 | nasdaq.com

Shockwave Medical (SWAV) Up 6.1% Since Last Earnings Report: Can It Continue? - Nasdaq

August 27, 2022 | finance.yahoo.com

Investors in Inogen (NASDAQ:INGN) have unfortunately lost 70% over the last five years - Yahoo Finance

August 27, 2022 | finance.yahoo.com

Investors in Inogen (NASDAQ:INGN) have unfortunately lost 70% over the last five years

August 18, 2022 | benzinga.com

Inogen's Return On Capital Employed Overview - Benzinga

August 9, 2022 | nasdaq.com

Is It Time To Consider Buying Inogen, Inc. (NASDAQ:INGN)? - Nasdaq

August 9, 2022 | seekingalpha.com

Inogen, Inc. (INGN) CEO Nabil Shabshab on Q2 2022 Results - Earnings Call Transcript

August 8, 2022 | finance.yahoo.com

Portable Oxygen Generator Market Worth USD 2421.67 million by 2027 | Drivers, Trends, Opportunities, Challenges | Developments, Revenue, Growth Rate | Key Players, Top Countries, Types, Applications - Yahoo Finance

August 6, 2022 | finance.yahoo.com

Is It Too Late To Consider Buying Inogen, Inc. (NASDAQ:INGN)?

August 4, 2022 | finance.yahoo.com

Inogen (INGN) Reports Q2 Loss, Tops Revenue Estimates

August 4, 2022 | businesswire.com

Inogen Announces Second Quarter 2022 Financial Results - Business Wire

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive INGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inogen and its competitors with MarketBeat's FREE daily newsletter.

INGN Company Calendar

Last Earnings: 8/04/2022
Today: 10/01/2022
Next Earnings (Estimated): 11/03/2022
Fiscal Year End: 12/31/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Surgical appliances & supplies
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:INGN
CUSIP: N/A
CIK: 1294133
Web: www.inogen.com
Phone: (805) 562-0500
Fax: N/A
Employees: 1,021
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $41.00
High Stock Price Forecast: $47.00
Low Stock Price Forecast: $30.00
Forecasted Upside/Downside: +68.9%
Consensus Rating: Hold
Rating Score (0-4): 2.25
Research Coverage: 4 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.25)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-6,330,000.00
Net Margins: -8.03%
Pretax Margin: -5.19%
Return on Equity: -5.35%
Return on Assets: -4.06%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 5.32
Quick Ratio: 4.75

Sales & Book Value

Annual Sales: $358 million
Price / Sales: 1.55
Cash Flow: $0.68 per share
Price / Cash Flow: 35.78
Book Value: $16.29 per share
Price / Book: 1.49

Miscellaneous

Outstanding Shares: 22,870,000
Free Float: 22,594,000
Market Cap: $555.28 million
Optionable: Optionable
Beta: 0.99

Key Executives

Mr. Nabil Shabshab (Age 57)
CEO, Pres & Director
Comp: $3.24M

Ms. Alison Perry Bauerlein (Age 41)
Co-Founder
Comp: $621.06k

Mr. Bart Sanford (Age 56)
Exec. VP of Operations
Comp: $558.22k

Dr. Stanislav Glezer M.D. (Age 49)
MBA, Exec. VP & CTO
Comp: $628.3k

Mr. George J. Parr (Age 51)
Exec. VP & Chief Commercial Officer
Comp: $799.95k

Ms. Kristin A. Caltrider (Age 54)
Exec. VP, CFO & Treasurer

Ms. Agnes Lee
Sr. VP of Investor Relations & Strategic Planning

Mr. Jason Somer (Age 54)
Exec. VP, Gen. Counsel & Corp. Sec.

Ms. Jennifer Yi Boyer
Exec. VP & Chief HR Officer

Mr. Matthew Pigeon
Investor Relations Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

INGN Stock - Frequently Asked Questions

Should I buy or sell Inogen stock right now?: 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Inogen in the last year. There are currently 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" INGN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in INGN, but not buy additional shares or sell existing shares.
View INGN analyst ratings or view top-rated stocks.
What is Inogen's stock price forecast for 2022?: 4 brokerages have issued 1 year price targets for Inogen's stock. Their INGN share price forecasts range from $30.00 to $47.00. On average, they anticipate the company's stock price to reach $41.00 in the next twelve months. This suggests a possible upside of 68.9% from the stock's current price.
View analysts price targets for INGN or view top-rated stocks among Wall Street analysts.
How have INGN shares performed in 2022?: Inogen's stock was trading at $34.00 at the beginning of 2022. Since then, INGN stock has decreased by 28.6% and is now trading at $24.28.
View the best growth stocks for 2022 here.
When is Inogen's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our INGN earnings forecast.
How were Inogen's earnings last quarter?: Inogen, Inc. (NASDAQ:INGN) released its quarterly earnings data on Thursday, August, 4th. The medical technology company reported ($0.02) earnings per share for the quarter, beating the consensus estimate of ($0.40) by $0.38. The medical technology company earned $103.38 million during the quarter, compared to analysts' expectations of $100.64 million. Inogen had a negative net margin of 8.03% and a negative trailing twelve-month return on equity of 5.35%. The company's revenue was up 1.8% compared to the same quarter last year. During the same quarter last year, the firm posted $0.22 earnings per share.
What guidance has Inogen issued on next quarter's earnings?: Inogen updated its third quarter 2022 earnings guidance on Thursday, September, 1st. The company provided EPS guidance of for the period. The company issued revenue guidance of $97.00 million-$100.00 million, compared to the consensus revenue estimate of $98.77 million.

What is Scott Wilkinson's approval rating as Inogen's CEO?: 70 employees have rated Inogen Chief Executive Officer Scott Wilkinson on Glassdoor.com. Scott Wilkinson has an approval rating of 46% among the company's employees. This puts Scott Wilkinson in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of Inogen own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Inogen investors own include Puma Biotechnology (PBYI), BioMarin Pharmaceutical (BMRN), Incyte (INCY), (MDVN) (MDVN), NVIDIA (NVDA), Alibaba Group (BABA), Advanced Micro Devices (AMD), First Solar (FSLR), Intel (INTC) and Netflix (NFLX).
What is Inogen's stock symbol?: Inogen trades on the NASDAQ under the ticker symbol "INGN."
How do I buy shares of Inogen?: Shares of INGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Inogen's stock price today?: One share of INGN stock can currently be purchased for approximately $24.28.
How much money does Inogen make?: Inogen (NASDAQ:INGN) has a market capitalization of $555.28 million and generates $358 million in revenue each year. The medical technology company earns $-6,330,000.00 in net income (profit) each year or ($1.25) on an earnings per share basis.
How many employees does Inogen have?: The company employs 1,021 workers across the globe.
How can I contact Inogen?: Inogen's mailing address is 326 BOLLAY DRIVE, GOLETA CA, 93117. The official website for the company is www.inogen.com. The medical technology company can be reached via phone at (805) 562-0500 or via email at mpigeon@inogen.net.

This page (NASDAQ:INGN) was last updated on 10/2/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Inogen - INGN Stock Forecast, Price & News

Inogen MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability